Article Details
Retrieved on: 2021-04-12 14:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company also has a phase 2 Lyme disease vaccine candidate called VLA15, which is part of a $308 million R&D deal penned with Pfizer last year ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here